Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001698530-25-000006
Filing Date
2025-01-23
Accepted
2025-01-23 07:58:33
Documents
15
Period of Report
2025-01-23
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A xcur-20250123.htm   iXBRL 8-K/A 24663
2 EX-99.1 ex991pressrelease12325.htm EX-99.1 15397
6 exicureimage1a10.gif GRAPHIC 2794
  Complete submission text file 0001698530-25-000006.txt   173820

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT xcur-20250123.xsd EX-101.SCH 1788
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT xcur-20250123_lab.xml EX-101.LAB 22532
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT xcur-20250123_pre.xml EX-101.PRE 13047
17 EXTRACTED XBRL INSTANCE DOCUMENT xcur-20250123_htm.xml XML 2708
Mailing Address 2430 N. HALSTED ST. CHICAGO IL 60614
Business Address 2430 N. HALSTED ST. CHICAGO IL 60614 847-673-1700
EXICURE, INC. (Filer) CIK: 0001698530 (see all company filings)

EIN.: 815333008 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-39011 | Film No.: 25547654
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)